6th Annual Myositis Empower Walk Sponsors

Did you know that the Myositis Empower Walk is not only fueled by people like you but also by generous sponsors? By supporting MSU’s Myositis Empower Walk, our sponsors are making a lasting impact for care partners and patients with myositis. Their support will continue to strengthen MSU’s mission and with their help, we can raise funds to continue to provide emotional and financial support for patients and to support research to better understand myositis, find treatments, and one day a cure. Learn more about our amazing sponsors for this year’s event.

Interested in becoming a sponsor? Contact us at empowerwalk@understandingmyositis.org for more information. 

EMPOWER SPONSORS

Abcuro is a clinical stage biotechnology company developing first-in-class immunotherapies for the treatment of autoimmune diseases and cancer through precise modulation of highly cytotoxic T cells. The company’s lead program is ulviprubart (ABC008) and is currently in clinical trials for inclusion body myositis (IBM) and T cell large granular lymphocytic leukemia.

Each day at argenx, we are motivated to pursue a better tomorrow alongside patients. We aim to do this through partnership because we know that “together we are better”. As your ally, we pioneer innovations to advance the understanding of rare diseases; we want to deliver immunology treatments to patients worldwide.

We listen to patients, supporters and advocacy communities; we hear your stories and share your determination. We integrate your aspirations into how we innovate, how we conduct research and design trials, and how we can support you in the daily struggles you face living with a rare disease.

INSPIRE SPONSORS

EMD Serono – the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada – aspires to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. The business is imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono’s global roots go back more than 350 years with Merck KGaA, Darmstadt, Germany. Today, the business has approximately 1,500 employees around the country with commercial, clinical and research operations in Massachusetts
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the greatest morbidity and mortality. They are developing oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications, unlocking new treatment options for patients who are underserved by existing therapies. The VALOR Study is a clinical study for adults (from 18 to 75 years old) with dermatomyositis who are not finding symptom relief with current treatment.
Plasma Services Group is a global leader in specialty antibody recruitment for the medical diagnostic industry. With over a decade of experience working with donors and diagnostic companies, PSG remains a cornerstone in medical research, connecting donors nationwide with diagnostic efforts around the world.